Found 6 matching trials
Study of the Absorption, Metabolism, and Excretion Following a Single Dose of [14C]-Poziotinib in Healthy Male Subjects PHASE1 This will be a Phase 1, open-label, nonrandomized, single-dose study in hea...
Show More Location
Covance Clinical Research Unit, Inc.
Learn More & Join Trial
Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation PHASE2 This is a Phase 2, open-label, multicenter study to evaluate the efficacy a...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation PHASE2 This is a Phase 2, open-label, multi-center study to evaluate the efficacy ...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer PHASE2 This phase II trial tests whether poziotinib and ramucirumab work to shrink...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies PHASE2 This is a Phase 2, open-label, multicenter study whose principal objectives...
Show More Location
Pacific Shores Medical Group
Learn More & Join Trial
Study of Poziotinib in Japanese Patients With NSCLC PHASE1 A Phase 1/2, open-label, multicenter study to determine dose, tolerability,...
Show More Location
National Cancer Center East
Learn More & Join Trial